Item Type | Name |
Concept
|
Cluster Headache
|
Concept
|
Headache
|
Concept
|
Tension-Type Headache
|
Concept
|
Headache Disorders
|
Concept
|
Headache Disorders, Primary
|
Concept
|
Headache Disorders, Secondary
|
Academic Article
|
14th International Headache Congress: clinical highlights.
|
Academic Article
|
Association between restless legs syndrome and migraine.
|
Academic Article
|
OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.
|
Academic Article
|
Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study.
|
Academic Article
|
Predicting the probability of relapse after discontinuation of migraine preventive treatment with topiramate.
|
Academic Article
|
Method of injection of onabotulinumtoxinA for chronic migraine: a safe, well-tolerated, and effective treatment paradigm based on the PREEMPT clinical program.
|
Academic Article
|
Defining the pharmacologically intractable headache for clinical trials and clinical practice.
|
Academic Article
|
Topiramate intervention to prevent transformation of episodic migraine: the topiramate INTREPID study.
|
Academic Article
|
Randomized, controlled trial of telcagepant over four migraine attacks.
|
Academic Article
|
A new frontier for headache.
|
Academic Article
|
Acetate causes alcohol hangover headache in rats.
|
Academic Article
|
Frovatriptan as preemptive treatment for fasting-induced migraine.
|
Academic Article
|
Current understanding and treatment of headache disorders: five new things.
|
Academic Article
|
MAP0004, orally inhaled DHE: a randomized, controlled study in the acute treatment of migraine.
|
Academic Article
|
OnabotulinumtoxinA for treatment of chronic migraine: a response.
|
Academic Article
|
Targeting sleep disruption using sodium oxybate in chronic cluster headache prophylaxis.
|
Academic Article
|
Diagnostic criteria for headache due to spontaneous intracranial hypotension: a perspective.
|
Academic Article
|
Sumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover study.
|
Academic Article
|
Efficacy and safety of MAP0004, orally inhaled DHE in treating migraines with and without allodynia.
|
Academic Article
|
Twelve-month tolerability and efficacy study of NP101, the sumatriptan iontophoretic transdermal system.
|
Academic Article
|
Spontaneous trigeminal allodynia in rats: a model of primary headache.
|
Academic Article
|
Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: Results from a randomized, multicenter, double-blinded, controlled study.
|
Academic Article
|
Migraine headache is present in the aura phase: a prospective study.
|
Academic Article
|
Randomized, double-blind, placebo-controlled, phase II trial of gabapentin enacarbil for migraine prophylaxis.
|
Academic Article
|
Expert consensus recommendations for the performance of peripheral nerve blocks for headaches - a narrative review.
|
Academic Article
|
Trigeminal autonomic cephalalgias other than cluster headache.
|
Academic Article
|
Use of common migraine treatments in breast-feeding women: a summary of recommendations.
|
Academic Article
|
Gastrointestinal manifestations of migraine: meeting the treatment challenges.
|
Academic Article
|
OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline.
|
Academic Article
|
Migraine genetics - a review: part I.
|
Academic Article
|
Migraine Genetics: Part II.
|
Academic Article
|
Tricyclic antidepressant medication, stress management therapy, and their combination in the management of chronic tension-type headache.
|
Academic Article
|
Drug overuse and rebound headache.
|
Academic Article
|
Is there a preferred triptan?
|
Academic Article
|
Control of topiramate-induced paresthesias with supplemental potassium.
|
Academic Article
|
Hemiplegic cluster.
|
Academic Article
|
Pharmacological profile and clinical characteristics of frovatriptan in the acute treatment of migraine: introduction.
|
Academic Article
|
Hemicrania continua.
|
Academic Article
|
Olanzapine in the treatment of refractory migraine and chronic daily headache.
|
Academic Article
|
Hemicrania continua responds to cyclooxygenase-2 inhibitors.
|
Academic Article
|
Diagnostic testing for chronic daily headache.
|
Academic Article
|
Painkiller headache.
|
Academic Article
|
Further evaluation of rizatriptan in menstrual migraine: retrospective analysis of long-term data.
|
Academic Article
|
Reliability and validity of the migraine therapy assessment questionnaire.
|
Academic Article
|
Intravenous propofol in the treatment of refractory headache.
|
Academic Article
|
Migraine preventive medication reduces resource utilization.
|
Academic Article
|
Ergotamine and dihydroergotamine: history, pharmacology, and efficacy.
|
Academic Article
|
Re: chronic daily headache in children and adolescents presenting to tertiary headache clinics.
|
Academic Article
|
Botulinum toxin type A: myths, facts, and current research.
|
Academic Article
|
Neurotoxins in the neurobiology of pain.
|
Academic Article
|
Procedures for administering botulinum toxin type A for migraine and tension-type headache.
|
Academic Article
|
Efficacy and tolerability of oral zolmitriptan in menstrually associated migraine: a randomized, prospective, parallel-group, double-blind, placebo-controlled study.
|
Academic Article
|
Headaches due to nasal and paranasal sinus disease.
|
Academic Article
|
Inpatient treatment of headache: an evidence-based assessment.
|
Academic Article
|
Anticonvulsants in migraine.
|
Academic Article
|
Consensus statement: cardiovascular safety profile of triptans (5-HT agonists) in the acute treatment of migraine.
|
Academic Article
|
Cardiovascular tolerability and safety of triptans: a review of clinical data.
|
Academic Article
|
Botulinum neurotoxin for the treatment of migraine and other primary headache disorders.
|
Academic Article
|
Study of mitochondrial DNA mutations in patients with migraine with prolonged aura.
|
Academic Article
|
Botulinum neurotoxin for the treatment of migraine and other primary headache disorders.
|
Academic Article
|
Headache management for the pain specialist.
|
Academic Article
|
Headaches in pregnancy.
|
Academic Article
|
MRI of a brain under pressure.
|
Academic Article
|
Topiramate in migraine prevention.
|
Academic Article
|
Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
|
Academic Article
|
Neuroleptics in headache.
|
Academic Article
|
Preventive treatment of headaches.
|
Academic Article
|
Chronic daily headache.
|
Academic Article
|
Therapeutic options in the management of headache attributed to rhinosinusitis.
|
Academic Article
|
The headache of SAH responds to sumatriptan.
|
Academic Article
|
Acetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: results from the ASSET trial.
|
Academic Article
|
Burden of illness and satisfaction with care among patients with headache seen in a primary care setting.
|
Academic Article
|
Botulinum toxin type A for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial.
|
Academic Article
|
Removing barriers to appropriate migraine treatment: formulary limitations and triptan package size.
|
Academic Article
|
Cervical epidural blood patch for low CSF pressure headaches.
|
Academic Article
|
Tramadol/acetaminophen for the treatment of acute migraine pain: findings of a randomized, placebo-controlled trial.
|
Academic Article
|
Headaches in pregnancy.
|
Academic Article
|
The Global Campaign (GC) to Reduce the Burden of Headache Worldwide. The International Team for Specialist Education (ITSE).
|
Academic Article
|
Hormone-related headache: pathophysiology and treatment.
|
Academic Article
|
Acetaminophen, aspirin, and caffeine in combination versus ibuprofen for acute migraine: results from a multicenter, double-blind, randomized, parallel-group, single-dose, placebo-controlled study.
|
Academic Article
|
Acute migraine treatment: patterns of use and satisfaction in a clinical population.
|
Academic Article
|
Reversible anorgasmia with topiramate therapy for headache: a report of 7 patients.
|
Academic Article
|
DHE in the pharmacotherapy of migraine: potential for a larger role.
|
Academic Article
|
Pharmacology of dihydroergotamine and evidence for efficacy and safety in migraine.
|
Academic Article
|
Central sensitization theory of migraine: clinical implications.
|
Academic Article
|
Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
|
Academic Article
|
Migrainous visual auras: a life history.
|
Academic Article
|
Hemicrania continua-like headache associated with internal carotid artery dissection may respond to indomethacin.
|
Academic Article
|
Cephalalgiaphobia: a possible specific phobia of illness.
|
Academic Article
|
Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study.
|
Academic Article
|
Evaluation of an electronic diary as a diagnostic tool to study headache and premenstrual symptoms in migraineurs.
|
Academic Article
|
Topiramate in migraine prophylaxis: long-term impact on resource utilization and cost.
|
Academic Article
|
Patients' preference for migraine preventive therapy.
|
Academic Article
|
Pharmacological approaches to managing migraine and associated comorbidities--clinical considerations for monotherapy versus polytherapy.
|
Academic Article
|
Efficacy of eletriptan in migraine-related functional impairment: functional and work productivity outcomes.
|
Academic Article
|
Dihydroergotamine for early and late treatment of migraine with cutaneous allodynia: an open-label pilot trial.
|
Academic Article
|
Less is not more: underutilization of headache medications in a university hospital emergency department.
|
Academic Article
|
The impact of topiramate on health-related quality of life indicators in chronic migraine.
|
Academic Article
|
Botulinum toxin type A for the treatment of headache: why we say yes.
|
Academic Article
|
Triptans: actions and reactions.
|
Academic Article
|
Multiple intracerebral hemorrhages after cervical epidural injections.
|
Academic Article
|
The headache management trial: a randomized study of coordinated care.
|
Academic Article
|
Intravenous lidocaine infusion for the treatment of post-acoustic neuroma resection headache: a case report.
|
Academic Article
|
Epidemiology, risk factors, and treatment of chronic migraine: a focus on topiramate.
|
Academic Article
|
Diagnosis and treatment of the menstrual migraine patient.
|
Academic Article
|
Menstrual migraine: case studies of women with estrogen-related headaches.
|
Academic Article
|
Is botulinum toxin useful in treating headache? Yes.
|
Academic Article
|
Migraine in the triptan era: lessons from epidemiology, pathophysiology, and clinical science.
|
Academic Article
|
Intravenous lidocaine in the treatment of refractory headache: a retrospective case series.
|
Academic Article
|
Clinical results of botulinum toxin type a treatment of migraine headache.
|
Academic Article
|
Migraine prophylaxis with botulinum toxin A is associated with perception of headache.
|
Academic Article
|
The evolution of chronic migraine: classification and nomenclature.
|
Academic Article
|
Headache prophylaxis with BoNTA: patient characteristics.
|
Academic Article
|
Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.
|
Academic Article
|
Scheduled short-term prevention with frovatriptan for migraine occurring exclusively in association with menstruation.
|
Academic Article
|
Safety and tolerability of short-term preventive frovatriptan: a combined analysis.
|
Academic Article
|
Expanding access to triptans: assessment of clinical outcome.
|
Academic Article
|
Choosing Wisely in Headache Medicine: The American Headache Society's List of Five Things Physicians and Patients Should Question.
|
Academic Article
|
Sumatriptan/naproxen sodium for the acute treatment of probable migraine without aura: A randomized study.
|
Academic Article
|
Comparing the efficacy of eletriptan for migraine in women during menstrual and non-menstrual time periods: a pooled analysis of randomized controlled trials.
|
Academic Article
|
Headaches caused by nasal and paranasal sinus disease.
|
Academic Article
|
Operational diagnostic criteria for chronic migraine: expert opinion.
|
Academic Article
|
Considerations in the treatment of tension-type headache in the elderly.
|
Academic Article
|
Acute migraine treatment.
|
Academic Article
|
The acute treatment of migraine in adults: the american headache society evidence assessment of migraine pharmacotherapies.
|
Academic Article
|
Episodic and chronic migraine headache: breaking down barriers to optimal treatment and prevention.
|
Academic Article
|
Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: Long-term results from a randomized, multicenter, double-blinded, controlled study.
|
Academic Article
|
AVP-825 Breath-Powered Intranasal Delivery System Containing 22?mg Sumatriptan Powder vs 100?mg Oral Sumatriptan in the Acute Treatment of Migraines (The COMPASS Study): A Comparative Randomized Clinical Trial Across Multiple Attacks.
|
Academic Article
|
Late-life migraine accompaniments: A narrative review.
|
Academic Article
|
Preventive Migraine Treatment.
|
Academic Article
|
Sumatriptan Iontophoretic Transdermal System Reduces Treatment-Emergent Nausea and Is Effective in Patients With and Without Nausea at Baseline - Results From a Randomized Controlled Trial.
|
Academic Article
|
Therapeutic Monoclonal Antibodies: What Headache Specialists Need to Know.
|
Academic Article
|
Vagus Nerve and Vagus Nerve Stimulation, a Comprehensive Review: Part I.
|
Academic Article
|
Vagus Nerve and Vagus Nerve Stimulation, a Comprehensive Review: Part III.
|
Academic Article
|
Vagus Nerve and Vagus Nerve Stimulation, a Comprehensive Review: Part II.
|
Academic Article
|
Case Report: Secondary SUNCT After Radiation Therapy-A Novel Presentation.
|
Academic Article
|
The Use of Botulinum Toxin in the Management of Headache Disorders.
|
Academic Article
|
The Management of Adults With Acute Migraine in the Emergency Department.
|
Academic Article
|
How to Apply the AHS Evidence Assessment of the Acute Treatment of Migraine in Adults to your Patient with Migraine.
|
Academic Article
|
The American Headache Society Cluster Guidelines.
|
Academic Article
|
Chronic migraine headache prevention with noninvasive vagus nerve stimulation: The EVENT study.
|
Academic Article
|
Non-Invasive Vagus Nerve Stimulation for the ACute Treatment of Cluster Headache: Findings From the Randomized, Double-Blind, Sham-Controlled ACT1 Study.
|
Academic Article
|
Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered® Exhalation Delivery System (Sumatriptan Nasal Powder) vs Oral Sumatriptan.
|
Academic Article
|
Insights into the Functional Anatomy Behind the PREEMPT Injection Paradigm: Guidance on Achieving Optimal Outcomes.
|
Academic Article
|
Temporarily Withdrawn: Choosing Wisely in Headache Medicine: The American Headache Society's List of Five Things Physicians and Patients Should Question.
|
Academic Article
|
Topiramate in Migraine Prevention: A 2016 Perspective.
|
Academic Article
|
Vagus Nerve Stimulation and Headache.
|
Academic Article
|
Neuropeptides.
|
Academic Article
|
AVP-825 (Sumatriptan Nasal Powder) Reduces Nausea Compared to Sumatriptan Tablets: Results of the COMPASS Randomized Clinical Trial.
|
Academic Article
|
The emerging role of gammaCore® in the management of cluster headache: expert panel recommendations.
|
Academic Article
|
The Use and Method of Action of Intravenous Lidocaine and Its Metabolite in Headache Disorders.
|
Academic Article
|
A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study).
|
Academic Article
|
Histamine and Migraine.
|
Academic Article
|
Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults.
|
Academic Article
|
Ketamine for Refractory Headache: A Retrospective Analysis.
|
Academic Article
|
Rationale for electrical parameter determination in external trigeminal nerve stimulation (eTNS) for migraine: A narrative review.
|
Academic Article
|
Health care Resource Utilization and Migraine Disability Along the Migraine Continuum Among Patients Treated for Migraine.
|
Academic Article
|
The Effect of Beginning Treatment With Fremanezumab on Headache and Associated Symptoms in the Randomized Phase 2 Study of High Frequency Episodic Migraine: Post-Hoc Analyses on the First 3 Weeks of Treatment.
|
Academic Article
|
Migraine Headache: Diagnosis and Current and Emerging Preventive Treatments.
|
Academic Article
|
Development of a claims-based algorithm to identify potentially undiagnosed chronic migraine patients.
|
Academic Article
|
Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth edition.
|
Academic Article
|
Safety and Tolerability of Fremanezumab for the Prevention of Migraine: A Pooled Analysis of Phases 2b and 3 Clinical Trials.
|
Academic Article
|
Remote Electrical Neuromodulation (REN) Relieves Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial.
|
Academic Article
|
Adherence to the 2008 IHS guidelines for controlled trials of drugs for the preventive treatment of chronic migraine in adults.
|
Academic Article
|
Vestibular Neuroscience for the Headache Specialist.
|
Academic Article
|
Basic Considerations for the Use of Monoclonal Antibodies in Migraine.
|
Academic Article
|
Targeting CGRP for the Prevention of Migraine and Cluster Headache: A Narrative Review.
|
Academic Article
|
Long-term safety and tolerability of erenumab: Three-plus year results from a five-year open-label extension study in episodic migraine.
|
Academic Article
|
Pathophysiology, prevention, and treatment of medication overuse headache.
|
Academic Article
|
Eptinezumab for prevention of chronic migraine: A randomized phase 2b clinical trial.
|
Academic Article
|
Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 & EVOLVE-2).
|
Academic Article
|
Differential efficacy of non-invasive vagus nerve stimulation for the acute treatment of episodic and chronic cluster headache: A meta-analysis.
|
Academic Article
|
Early onset of effect of onabotulinumtoxinA for chronic migraine treatment: Analysis of PREEMPT data.
|
Academic Article
|
Novel Medications for the Treatment of Migraine.
|
Academic Article
|
FORWARD Study: Evaluating the Comparative Effectiveness of OnabotulinumtoxinA and Topiramate for Headache Prevention in Adults With Chronic Migraine.
|
Academic Article
|
Neuroimaging for Migraine: The American Headache Society Systematic Review and Evidence-Based Guideline.
|
Academic Article
|
Correction to: Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 & EVOLVE-2).
|
Academic Article
|
Long-term tolerability and nonvascular safety of erenumab, a novel calcitonin gene-related peptide receptor antagonist for prevention of migraine: A pooled analysis of four placebo-controlled trials with long-term extensions.
|
Academic Article
|
Dihydroergotamine (DHE) - Then and Now: A Narrative Review.
|
Academic Article
|
The Influence of Migraine on Driving: Current Understanding, Future Directions, and Potential Implications of Findings.
|
Academic Article
|
Have the IHS Guidelines for controlled trials of acute treatment of migraine attacks been followed? Laying the ground for the 4th edition.
|
Academic Article
|
Comparison of healthcare resource utilization and costs among patients with migraine with potentially adequate and insufficient triptan response.
|
Academic Article
|
Long-term safety and efficacy of erenumab in patients with chronic migraine: Results from a 52-week, open-label extension study.
|
Academic Article
|
Mechanism of Action of OnabotulinumtoxinA in Chronic Migraine: A Narrative Review.
|
Academic Article
|
The Use of Botulinum Toxin in the Management of Headache Disorders.
|
Academic Article
|
Non-invasive vagus nerve stimulation for primary headache: A clinical update.
|
Academic Article
|
Headache and rhinosinusitis: A review.
|
Academic Article
|
The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study.
|
Academic Article
|
Eptinezumab for the prevention of chronic migraine: efficacy and safety through 24?weeks of treatment in the phase 3 PROMISE-2 (Prevention of migraine via intravenous ALD403 safety and efficacy-2) study.
|
Academic Article
|
The Impact of OnabotulinumtoxinA vs. Placebo on Efficacy Outcomes in Headache Day Responder and Nonresponder Patients with Chronic Migraine.
|
Academic Article
|
Reversion from chronic migraine to episodic migraine following treatment with erenumab: Results of a post-hoc analysis of a randomized, 12-week, double-blind study and a 52-week, open-label extension.
|
Academic Article
|
Correction to: The Use of Botulinum Toxin in the Management of Headache Disorders.
|
Academic Article
|
Treatment benefit among migraine patients taking fremanezumab: results from a post hoc responder analysis of two placebo-controlled trials.
|
Academic Article
|
Response to "Modifications to the PREEMPT Protocol for OnabotulinumtoxinA Injections for Chronic Migraine in Clinical Practice".
|
Academic Article
|
Evaluation of the 6-item Identify Chronic Migraine screener in a large medical group.
|
Academic Article
|
Benefits Beyond Headache Days With OnabotulinumtoxinA Treatment: A Pooled PREEMPT Analysis.
|
Academic Article
|
Safety and efficacy of ubrogepant in participants with major cardiovascular risk factors in two single-attack phase 3 randomized trials: ACHIEVE I and II.
|
Academic Article
|
Guidelines of the International Headache Society for clinical trials with neuromodulation devices for the treatment of migraine.
|
Academic Article
|
A new hypothesis linking oxytocin to menstrual migraine.
|
Academic Article
|
Time course of efficacy of atogepant for the preventive treatment of migraine: Results from the randomized, double-blind ADVANCE trial.
|
Academic Article
|
Chronic versus episodic migraine: The 15-day threshold does not adequately reflect substantial differences in disability across the full spectrum of headache frequency.
|
Academic Article
|
Intravenous ibuprofen for acute treatment of migraine: A double-blind, randomized, placebo-controlled pilot study.
|
Academic Article
|
Guidelines of the International Headache Society for Clinic-Based Headache Registries, 1st edition.
|
Academic Article
|
Lidocaine infusions for refractory chronic migraine: a retrospective analysis.
|
Academic Article
|
Safety and tolerability of fremanezumab in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies.
|